Clinical Trial Update: ORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study [Phase 2]

View source ↗

Summary

A Phase 2 long-term follow-up study evaluating the safety of GT005 in participants with geographic atrophy secondary to age-related macular degeneration ongoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• GT005

Snippet

Sponsor: Gyroscope Therapeutics Limited | Conditions: Age Related Macular Degeneration (AMD) | Phase 2 | Status: ENROLLING_BY_INVITATION